Clinical Trials in Phoenix

Showing 6121-6140 of 12,606 trials

OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection

NCT04194398

Collection of five year follow-up data on patients who have already participated in the EXPAND Lung trial and have had transplants with donor lungs preserved on the OCS Lung System.

OCS Lung System

TransMedics79 participantsStarted Dec 2018

Phoenix, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +5 more locations

UNKNOWNPhase 4< 1 mile

Improving Pain Management and Decreasing LOS After Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA)

NCT05307341

This two arm, patient blinded, randomized, post market clinical trial in a single orthopedic hospital will determine whether there is improved pain management and decreased length of stay when comparing standard of care pain management with and without sufentanil.

Pain

More Foundation100 participantsStarted Mar 2022

Phoenix, Arizona, United States

COMPLETEDPhase 211 miles

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

NCT04018027

This is a multicenter, randomized, double-blind, 4-arm, placebo-controlled study to evaluate the efficacy and safety of twice-daily (BID) oral difelikefalin (CR845) in adult subjects with atopic dermatitis (AD) and moderate to severe pruritus.

PruritusAtopic Dermatitis

Cara Therapeutics, Inc.401 participantsStarted Jun 2019

Anniston, Alabama, United States • Birmingham, Alabama, United States • Scottsdale, Arizona, United States +37 more locations

OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection

Improving Pain Management and Decreasing LOS After Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA)

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

Find Trials by Condition in Phoenix

Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer

Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older

An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps

A Study of Oral Contraception Under Simulated OTC Conditions

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

Reducing Involuntary Movements in Participants With Tardive Dyskinesia

Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure

Combination Study for High Risk Multiple Myeloma Patients

Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors

Post Market Study of the 3DKnee™ With E-plus Insert

Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

Repeat Antenatal Steroids Trial

QuikClot Control+ Hemostatic Dressing Use in Mild to Moderate Bleeding

Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease)